Showing results (131-140 of 242) with videos related to

Sort By:
Pageof 25
British Journal of Cancer|January 1, 1985
The effect of systemic hyperthermia on melphalan pharmacokinetics in miceD J Honess, J Donaldson, P Workman, et al.
Biochemical Pharmacology|November 16, 2001
Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potentialP A Clarke, R te Poele, R Wooster, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinonesS M Bailey, N Suggett, M I Walton, et al.
Neurobiology of Aging|October 26, 2021
Sex differences in cognitive aging: a 4-year longitudinal study in marmosetsEmily S Rothwell, Kathryn P Workman, Dongwei Wang, et al.
Biochemical Pharmacology|January 7, 1998
Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554)E O Aboagye, A D Lewis, M Tracy, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1988
Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)H F Newman, N M Bleehen, R Ward, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1988
The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)H F Newman, R Ward, P Workman, et al.
Anti-Cancer Drug Design|October 2, 1998
Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomographyE O Aboagye, A B Kelson, M Tracy, et al.
Oncogene|October 19, 1999
Increased dosage and amplification of the focal adhesion kinase gene in human cancer cellsM Agochiya, V G Brunton, D W Owens, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
A multiple dose study of the combined radiosensitizers Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)N M Bleehen, H F Newman, T S Maughan, et al.
Pageof 25